Novant Health Activates Sites for COVID-19 Anti-Viral Study in Record Time: Can Leronlimab Help SARS-CoV-2 Patients?

Novant Health will be one of the first clinical investigational sites to study whether a medication called leronlimab could be used to treat SARS-CoV-2, the virus behind the COVID-19 pandemic. Previously, leronlimab has been used in combination with medications to...

Pin It on Pinterest